While in patients without any inflammation plasma-NGAL might be a reliable marker to identify a new onset of AKI, in patients with ongoing mild to moderate inflammation the diagnostic value of plasma-NGAL for the detection of AKI might be restricted. The gene discussed is LCN2; the disease is acute kidney injury.